Eli Lilly and Company utilizes Dell Technologies' infrastructure to advance its AI-driven drug discovery and global manufacturing.
The partners highlighted this ongoing collaboration on May 20, 2026.
Lilly deploys Dell's compute and storage capabilities from research laboratories to the factory floor.
This technology accelerates the delivery of new medicines for obesity, Alzheimer's, and cancer.
The investment enhances Lilly's research pipeline and manufacturing efficiency.